Retina experts deliberate on the role of fluorescein angiography in AMD and discuss initiation of anticomplement therapy for geographic atrophy in conjunction with anti-VEGF therapy for neovascular AMD.
Procedure can reduce scleral biomechanical stiffness and rejuvenate dynamic range of focus.
A conversation with David S. Friedman, MD, PhD, on treating uncontrolled open-angle glaucoma in patients with limited options
The procedure offers a renewed approach to suprachoroidal drainage, with potential for both combined and standalone glaucoma surgery.
TAKE-HOME: This affordable device allows the view through a slit lamp to be shared in real time or recorded, for teaching and reference purposes.
Spaceflight-associated neuro-ocular syndrome a potential challenge during long missions.
The TEASE-1 trial reveals gildeuretinol's potential to reduce vision loss in Stargardt disease, offering hope for future treatments.
Nadia K. Waheed, MD, MPH, and David M. Brown, MD, discuss the future of intravitreal injections.
Retinal specialists conclude their discussion with key highlights from each patient case of retinal vascular disease and pearls the audience can apply in their practice.
A panelist discusses how different phacoemulsification technologies, including vacuum-based and fluid-based systems like the Quatera 700, impact surgical efficiency and chamber stability during cataract procedures, emphasizing the importance of optimized fluidics settings for safe outcomes.
Extend the summer at EyeCon 2025—where clinical insight meets coastal vibes—September 26 and 27 at the Margaritaville Hollywood Beach Resort in Florida.
Language can drive understanding, trust, and better outcomes for patients
At ARVO 2025, in Salt Lake City, Utah, Ferhina Ali, MD, MPH, talked about her presentation on the early real-world use of aflibercept 8 mg in treatment-naive patients with neovascular age-related macular degeneration
During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye
Deep learning discerns IIH, NAION, and normal eyes using single fundus image.
Siloam Vision and Orbis team up to develop infrastructure to save the vision of premature infants.
In this final episode, DMEI’s residents share their future plans for expanding the device capabilities and offer practical advice to other up-and-coming creators in eye care technology.
Ahead of the September 8 meeting in Paris, the program co-chair of the event and current president of the American Academy of Ophthalmology discusses how the workshop aims to shape consensus on guidelines, research priorities, and emerging therapies in myopia control.
CAM’s regenerative healing means long-term relief and fewer visits to clinic.
Advanced monitoring strategies are overcoming significant obstacles in retinal care, as highlighted at the 2025 International SPECTRALIS Symposium — And Beyond (ISS).
Investigators continue to break new ground, giving hope to patients, physicians.
At the EnVision Summit 2025 in San Juan, Puerto Rico, Tania Tai, Lucy Shen, and Shivani Kamat all gave insight into complications they have seen while performing glaucoma surgery.
At the Envision Summit 2025 in San Juan, Puerto Rico, Amy Zhang, MD, discussed the importance of ergonomics in the operating room.
Patients’ reluctance to visit a clinic during the COVID-19 pandemic is pushing retina specialists to optimize therapy.
Recapping the Heidelberg Engineering International SPECTRALIS Symposium—and Beyond.
Need to eliminate errors results in optimization of training of novice surgeons.
Keratopigmentation technique offers therapeutic and cosmetic applications.